Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bioxcel Therapeutics Inc
(NQ:
BTAI
)
0.6790
+0.0269 (+4.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bioxcel Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 06, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8...
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
April 06, 2022
Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales...
Via
Benzinga
Why BioXcel Therapeutics Stock Is Surging Today
April 06, 2022
BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading higher Wednesday after the company announced that the U.S. Food and Drug Administration approved IGALMI (...
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 06, 2022
Gainers Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 17.5% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $47.6...
Via
Benzinga
FDA Approves BioXcel's Igalmi - First Orally Dissolving Sublingual Film For Schizophrenia-Associated Agitation
April 06, 2022
The
Via
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with...
Via
Benzinga
Recap: BioXcel Therapeutics Q4 Earnings
March 10, 2022
BioXcel Therapeutics (NASDAQ:BTAI) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
February 15, 2022
BioXcel Therapeutics Inc (NASDAQ: BTAI) announced results from its ongoing Phase 2 trial of BXCL701 in metastatic castration-resistant prostate cancer (mCRPC) patients with...
Via
Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
December 01, 2021
The FDA has extended the review period for BioXcel Therapeutics Inc's (NASDAQ: BTAI) marketing application seeking approval for BXCL501 for the acute...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
December 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 01, 2021
Gainers Ardelyx (NASDAQ:ARDX) stock increased by 19.29% to $1.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $153.3...
Via
Benzinga
Why BioXcel Therapeutics Is Down Sharply This Week
November 19, 2021
A double downgrade from an analyst on Wall Street is causing investors to think twice about the company's first new drug launch.
Via
The Motley Fool
Mid-Afternoon Market Update: Telos Falls After Q3 Results; Creative Realities Shares Spike Higher
November 15, 2021
Toward the end of trading Monday, the Dow traded down 0.05% to 36,082.17 while the NASDAQ fell 0.35% to 15,806.01. The S&P also fell, dropping 0.11% to 4,677.64. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
70 Biggest Movers From Yesterday
November 16, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...
Via
Benzinga
Why BioXcel Therapeutics Stock Is Crashing Today
November 15, 2021
An analyst downgraded the stock.
Via
The Motley Fool
12 Health Care Stocks Moving In Monday's Intraday Session
November 15, 2021
Gainers Tricida (NASDAQ:TCDA) shares rose...
Via
Benzinga
Mid-Day Market Update: Nasdaq Turns Lower; Casper Sleep Shares Jump
November 15, 2021
Midway through trading Monday, the Dow traded up 0.05% to 36,117.49 while the NASDAQ fell 0.29% to 15,815.61. The S&P also fell, dropping 0.06% to 4,679.81. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
41 Stocks Moving In Monday's Mid-Day Session
November 15, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Tyson Foods Posts Upbeat Q4 Results
November 15, 2021
Following the market opening Monday, the Dow traded up 0.27% to 36,196.19 while the NASDAQ rose 0.26% to 15,902.90. The S&P also rose, gaining 0.24% to 4,693.92. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
November 15, 2021
Upgrades For Targa Resources Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 15, 2021
Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 15, 2021
Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!
Via
InvestorPlace
10 Biggest Price Target Changes For Monday
November 15, 2021
Keybanc boosted the price target on Netflix, Inc. (NASDAQ: NFLX) from $690 to $725. Netflix shares rose 0.2% to $683.90 in pre-market trading. Piper Sandler raised the price...
Via
Benzinga
This High-Risk, High-Reward Stock Might Double Your Money
October 20, 2021
After a difficult year, shares of this biotech could bounce back big.
Via
The Motley Fool
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.